Zoledron 4 Mg Injection (Zoledronic Acid)
$83.03 – $182.72Price range: $83.03 through $182.72RxRequired
-
United States dollar ($) - USD
-
Euro (€) - EUR
-
Canadian dollar ($) - CAD
| Pack Size | Price | Unit Price | Quantity | |
|---|---|---|---|---|
| 2 Injection | $83.03 | $41.52 / injection | ||
| 4 Injection | $133.51 | $33.38 / injection | ||
| 6 Injection | $182.72 | $30.45 / injection |
Add $199.00 to cart and get free shipping!
About Zoledron 4 Mg Injection (Zoledronic Acid)
Medicine information
- Active ingredient
- Zoledronic acid
- Indication
- Treatment of hypercalcemia of malignancy and prevention of skeletal complications in patients with multiple myeloma or documented bone metastases from solid tumors, when used with standard antineoplastic treatment.
- Manufacturer
- Shantha Biotechnics Pvt. Ltd.
- Packaging
- Dry vial containing 1 powder for injection.
- Strength
- 4 mg
- Dosage form
- Powder for injection
- Route
- Intravenous infusion after reconstitution and dilution
Medicine overview
Zoledron 4 Mg Injection contains zoledronic acid, a bisphosphonate medicine that reduces excessive breakdown of bone. This 4 mg product is administered by intravenous infusion under medical supervision. Zoledronic acid 4 mg formulations are used particularly for high blood calcium caused by cancer and for reducing skeletal complications in people with multiple myeloma or solid tumors that have spread to bone. Kidney function, calcium and other relevant laboratory values require assessment during treatment.
What it is used for
Zoledronic acid 4 mg is used to treat hypercalcemia of malignancy, meaning an abnormally high blood calcium level caused by cancer. It is also used with standard cancer treatment in patients with multiple myeloma and documented bone metastases from solid tumors to help reduce skeletal complications associated with cancer involving bone. The appropriate indication and treatment schedule are determined by the treating clinician.
How it works
Zoledronic acid belongs to the bisphosphonate class. It has a strong affinity for mineralized bone and inhibits osteoclast-mediated bone resorption. Osteoclasts are cells that normally break down bone tissue. Suppressing excessive osteoclast activity slows the release of calcium from bone and reduces abnormal bone destruction. This action helps lower elevated calcium in hypercalcemia of malignancy and helps limit skeletal complications when cancer has affected bone.
How it is taken
Zoledron is administered intravenously by a healthcare professional and should not be self-administered. For zoledronic acid 4 mg cancer-related formulations, the prepared dose is given as an intravenous infusion lasting no less than 15 minutes. Kidney function should be assessed before treatment, and patients with hypercalcemia of malignancy should be adequately hydrated before administration. Zoledronic acid must not be mixed with calcium-containing or other divalent-cation-containing infusion solutions. The exact dose and treatment interval depend on the indication and renal function.
Important warnings
Zoledronic acid must not be used in patients with hypersensitivity to zoledronic acid or product components. It can cause renal deterioration, including renal failure; serum creatinine should be assessed before treatment, and greater caution is required with renal impairment or other nephrotoxic medicines. Hypocalcemia can occur and should be corrected when appropriate, with calcium, phosphate and magnesium monitored as clinically indicated. Osteonecrosis of the jaw has been reported, particularly in cancer patients, so a dental examination and appropriate preventive dentistry are advised before treatment; invasive dental procedures should generally be avoided during therapy where possible. Serious hypersensitivity reactions, including anaphylaxis, can occur. Patients receiving zoledronic acid should not simultaneously receive another medicine containing the same active ingredient, and concurrent bisphosphonate therapy should be avoided. Aminoglycosides, loop diuretics and nephrotoxic medicines require particular caution because they may increase calcium or kidney-related risks.
Side effects and monitoring
Common adverse effects reported with zoledronic acid 4 mg include nausea, fatigue, anemia, bone pain, constipation, fever, vomiting and shortness of breath. Flu-like or acute-phase symptoms such as fever, chills and muscle or bone aches can occur after an infusion. Important less common or serious risks include kidney impairment or renal failure, hypocalcemia, osteonecrosis of the jaw, severe hypersensitivity reactions and atypical femoral fractures. Kidney function should be monitored, including serum creatinine before relevant doses, and calcium and other electrolytes may require monitoring. Seek prompt medical attention for severe allergic symptoms, markedly reduced urination, muscle spasms or tingling suggestive of low calcium, new jaw pain or poor healing in the mouth, or unusual thigh or groin pain.
Pregnancy
Zoledronic acid can cause fetal harm based on its pharmacology and animal data. Treatment should not be used during pregnancy unless specifically determined appropriate by the treating specialist; pregnancy should be reported to the treating clinician promptly.
Breastfeeding
Breastfeeding is not recommended during and after zoledronic acid treatment because it is unknown whether the medicine is present in human milk and zoledronic acid remains bound to bone for a prolonged period.
Food and drink
There is no relevant food timing for this intravenous medicine. Adequate hydration is important, particularly when zoledronic acid is being used for hypercalcemia of malignancy, although excessive hydration should be avoided in patients at risk of fluid overload.
Frequently asked questions
Will I feel unwell after my first zoledronic acid infusion?
Flu-like symptoms such as fever, chills, aches and bone or muscle pain can occur after zoledronic acid. Tell your healthcare team if symptoms are severe, persistent or concerning.
Why does my dentist need to know that I receive zoledronic acid?
Zoledronic acid is associated with osteonecrosis of the jaw, a rare but potentially serious condition involving damaged jawbone. A dental examination and preventive dental care are recommended before treatment, and invasive dental procedures should generally be avoided during therapy where possible.
Can zoledronic acid affect my kidneys?
Yes. Zoledronic acid can impair kidney function and, in serious cases, renal failure has occurred. Kidney function is assessed before treatment, and the risk is particularly important in people with existing renal impairment or other kidney risk factors.
Why are calcium levels checked during treatment?
Zoledronic acid can lower blood calcium. Calcium and other relevant electrolytes may therefore require monitoring, and calcium and vitamin D supplementation may be prescribed for some indications.
How long does a 4 mg zoledronic acid infusion take?
The 4 mg dose should be administered by intravenous infusion over no less than 15 minutes. Faster administration can increase the risk of kidney toxicity.
Can I give Zoledron 4 Mg Injection to myself at home?
No. This medicine requires preparation and intravenous administration by an appropriately trained healthcare professional; it should not be self-administered.
Can I have dental work while receiving zoledronic acid?
Tell both your dentist and treating clinician before dental treatment. Because invasive dental procedures can be a concern in patients at risk of osteonecrosis of the jaw, dental care should be coordinated with your healthcare team.
Does Cheap Generic Med ship Zoledron internationally?
Cheap Generic Med serves multiple international destinations, but product-specific shipping availability for Zoledron 4 Mg Injection is NOT VERIFIED. Injectable medicines may also be subject to prescription, carrier, customs and destination-country requirements.
Sources
Medical information notice: This information does not replace advice from a qualified healthcare professional. Use prescription medicine only as directed by the prescriber and the approved product information.
| Active Ingredients | Zoledronic acid (4Mg) |
|---|---|
| Manufacturer | Shantha Biotech |
| Packaging | Qty |
| strength | 4mg |
| Delivery Time | 6 To 15 days |

Reviews
There are no reviews yet.